Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Windlas Biotech Ltd

WINDLAS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$9.95

▼ -0.01%

Market Cap $205.29M · Vol 143.02K

Key Metrics

P/E Ratio

30.47

FWD: N/A

Market Cap

$205.29M

Micro Cap

Div Yield

0.66%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

64.43

Momentum

Beta

0.62

vs Market

52W High

$11.50

21.13% below

52W Low

$7.31

31.57% above

Volume

143.02K

Avg 134.41K

P/B

2.68

Price-to-book

ROE

N/A

Return on equity

Free Float

33.78%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Windlas Biotech Ltd (WINDLAS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does WINDLAS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+7.54%

+11.56%

+24.54%

+17.96%

YTD

+19.42%

-9.36%

+115.47%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$96.74M
Net Income	$7.11M
Revenue Growth (YoY)	+18.09%
Gross Margin	31.84%
Operating Margin	8.18%
Net Profit Margin	7.35%
ROE	N/A
ROA · ROIC	10.43% · 12.14%

P/E Ratio	30.47
Forward P/E (FY1)	N/A
PEG Ratio	2.99
P/S	1.74
P/B	2.68
P/FCF	46.55
EPS Growth	N/A
Outstanding Shares	20.64M

Technical Indicators

50-Day SMA	$8.96
200-Day SMA	$8.57
RSI (14)	64.43
Beta	0.62
52-Week High	$11.50
52-Week Low	$7.31

Volume Today	143.02K
Avg Daily Volume (30D)	134.41K
Relative Volume	1.06x
Volatility (10D)	74.16
Volatility (30D)	47.21
Free Float	33.78%

Analyst Consensus

N/A

Current Price $9.95

Mean Target N/A

52W Low$7.31 52W High$11.50

Current

Target

$7.31 $11.50

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG009XQMZ68

ISININE0H5O01029

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables.